To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease.
作者信息
Takagi Hisato, Ando Tomo, Umemoto Takuya
机构信息
Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.
Department of Cardiology, Detroit Medical Center, Detroit, MI, USA.
出版信息
J Thorac Dis. 2016 Nov;8(11):3034-3039. doi: 10.21037/jtd.2016.11.103.
Abstract
摘要
相似文献
1
To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease.
J Thorac Dis. 2016 Nov;8(11):3034-3039. doi: 10.21037/jtd.2016.11.103.
2
One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601. doi: 10.2459/JCM.0b013e32801051f4.
3
Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
N Engl J Med. 2015 Mar 26;372(13):1213-22. doi: 10.1056/NEJMoa1412168. Epub 2015 Mar 16.
4
Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients.
Am J Cardiol. 2009 Jan 15;103(2):203-11. doi: 10.1016/j.amjcard.2008.08.068. Epub 2008 Nov 19.
5
Hybrid coronary revascularization in the era of drug-eluting stents.
Ann Thorac Surg. 2004 Nov;78(5):1861-7. doi: 10.1016/j.athoracsur.2004.07.024.
6
[Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
Anadolu Kardiyol Derg. 2009 Aug;9(4):325-30.
7
One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
Atherosclerosis. 2019 May;284:102-109. doi: 10.1016/j.atherosclerosis.2019.02.022. Epub 2019 Mar 3.
8
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Catheter Cardiovasc Interv. 2008 Oct 1;72(4):448-56. doi: 10.1002/ccd.21666.
9
Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.
Circ Cardiovasc Interv. 2015 Jul;8(7):e002626. doi: 10.1161/CIRCINTERVENTIONS.115.002626.
10
Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
J Am Coll Cardiol. 2015 Sep 15;66(11):1209-1220. doi: 10.1016/j.jacc.2015.06.1334.
本文引用的文献
1
Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
Am Heart J. 2016 Sep;179:157-65. doi: 10.1016/j.ahj.2016.06.020. Epub 2016 Jul 7.
2
Survival after percutaneous coronary intervention for chronic total occlusion.
Clin Res Cardiol. 2016 Nov;105(11):921-929. doi: 10.1007/s00392-016-1000-2. Epub 2016 Jun 1.
3
Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):3-12. doi: 10.1002/ccd.25923. Epub 2015 Apr 2.
4
Long-term outcomes of complete versus incomplete revascularization for patients with multivessel coronary artery disease and left ventricular systolic dysfunction in drug-eluting stent era.
J Korean Med Sci. 2014 Nov;29(11):1501-6. doi: 10.3346/jkms.2014.29.11.1501. Epub 2014 Nov 4.
5
A meta-analysis of adjusted risk estimates for survival from observational studies of complete versus incomplete revascularization in patients with multivessel disease undergoing coronary artery bypass grafting.
Interact Cardiovasc Thorac Surg. 2014 May;18(5):679-82. doi: 10.1093/icvts/ivu012. Epub 2014 Feb 13.
6
Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents.
Am J Cardiol. 2013 Sep 15;112(6):775-81. doi: 10.1016/j.amjcard.2013.05.003. Epub 2013 Jun 4.
7
Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
J Am Coll Cardiol. 2013 Oct 15;62(16):1421-31. doi: 10.1016/j.jacc.2013.05.033. Epub 2013 Jun 7.
8
Long-term outcomes of complete versus incomplete revascularization after drug-eluting stent implantation in patients with multivessel coronary disease.
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):343-9. doi: 10.1002/ccd.24799. Epub 2013 Apr 16.
9
Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era.
Circ J. 2012;76(7):1624-30. doi: 10.1253/circj.cj-11-1285. Epub 2012 Apr 14.
10
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
Eur J Cardiothorac Surg. 2012 Mar;41(3):535-41. doi: 10.1093/ejcts/ezr105. Epub 2011 Dec 21.
Zotero 插件